Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human TrkA Antibody, R&D Systems™

Goat Polyclonal Antibody has been used in 9 publications
Supplier: R&D Systems AF175
This item is not returnable.
View return policy
Description
TrkA Polyclonal specifically detects TrkA in Human samples. It is validated for Western Blot, Flow Cytometry, Immunohistochemistry, Neutralization, CyTOF-ready.Specifications
| TrkA | |
| Polyclonal | |
| Unconjugated | |
| AAA36770 | |
| NTRK1 | |
| Mouse myeloma cell line NS0-derived recombinant human TrkA Ala33-Glu407 Accession # AAA36770 | |
| 100 μg | |
| Primary | |
| Detects human TrkA in direct ELISAs and Western blots. In direct ELISAs, approximately 50% cross-reactivity with recombinant rat TrkA is observed and 10% cross-reactivity with recombinant human (rh) TrkB and rhTrKC is observed. | |
| Human | |
| IgG |
| Western Blot, Flow Cytometry, Immunohistochemistry, Neutralization, CyTOF | |
| LYOPH | |
| Western Blot 1 ug/mL, Flow Cytometry 2.5 ug/10^6 cells, Immunohistochemistry 5-15 ug/mL, Neutralization 3-12 ug/mL, CyTOF-ready | |
| DKFZp781I14186, EC 2.7.10, EC 2.7.10.1, MTChigh affinity nerve growth factor receptor, Neurotrophic tyrosine kinase receptor type 1, neurotrophic tyrosine kinase, receptor, type 1, NTRK1, NTRK-1, p140-TrkA, TRK1-transforming tyrosine kinase protein, Trk-A, TRKAOncogene TRK, TRKTRK1, tyrosine kinase receptor A | |
| Goat | |
| Affinity Purified | |
| RUO | |
| 4914 | |
| Reconstitute at 0.2 mg/mL in sterile PBS. | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction